Interaction of the imidazolone derivative GPA 1851 with hepatic microsomal drug metabolism.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D001463:Barbiturates / Q000494:pharmacology; D001555:Benzene Derivatives / Q000008:administration & dosage / Q000494:pharmacology; D001580:Benzopyrenes; D004285:Dogs; D004347:Drug Interactions; D004357:Drug Synergism; D005260:Female; D000882:Haplorhini; D006591:Hexobarbital / Q000494:pharmacology; D006900:Hydroxylation; D007093:Imidazoles / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D007700:Kinetics; D008251:Macaca; D008862:Microsomes, Liver / Q000201:enzymology / Q000378:metabolism*; D006899:Mixed Function Oxygenases / Q000378:metabolism; D010424:Pentobarbital / Q000097:blood; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D001463:Barbiturates; D001555:Benzene Derivatives; D001580:Benzopyrenes; D007093:Imidazoles; D011335:Proadifen; D006591:Hexobarbital; D006899:Mixed Function Oxygenases; D010424:Pentobarbital